Intelligent Pharmaceutical Systems for Personalized Medicine

The present inventive concept integrates pharmaceutical compositions comprising venglustat with distinct technologies such as AI, IoT, blockchain, and machine learning to create a new, more powerful system for personalized medicine, enabling real-time monitoring, adaptive dosing, and secure data management.

The original patent disclosed pharmaceutical compositions comprising venglustat, but lacked the ability to adapt to individual patient needs, ensure data integrity, and provide real-time feedback. The new inventive concept addresses these limitations by combining venglustat with innovative technologies to create a more effective and efficient system.

The new inventive concept comprises a pharmaceutical composition comprising venglustat, in free base or pharmaceutically acceptable salt form, integrated with an AI-powered dosing controller, IoT-enabled devices, blockchain-based secure data storage, and machine learning algorithms. The AI-powered dosing controller adjusts dosing regimens based on patient-specific factors and real-time health data. The IoT-enabled devices track patient adherence and provide real-time feedback to healthcare providers. The blockchain-based secure data storage ensures data integrity and confidentiality for patient health records. The machine learning algorithm predicts optimal dosing regimens based on patient genomics and medical history.

The new inventive concept is novel and non-obvious in its integration of venglustat with AI, IoT, blockchain, and machine learning technologies to create a personalized medicine system that adapts to individual patient needs, ensuring real-time monitoring, adaptive dosing, and secure data management.

Alternative embodiments of the inventive concept could include the use of other AI algorithms, different IoT devices, or alternative blockchain platforms. Additionally, the inventive concept could be adapted for use with other pharmaceutical compositions or therapeutic agents.

The inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine, precision health, and digital therapeutics. The target market includes pharmaceutical companies, healthcare providers, and patients seeking more effective and efficient treatment options.